vs

Side-by-side financial comparison of MONRO, INC. (MNRO) and MYRIAD GENETICS INC (MYGN). Click either name above to swap in a different company.

MONRO, INC. is the larger business by last-quarter revenue ($293.4M vs $209.8M, roughly 1.4× MYRIAD GENETICS INC). On growth, MYRIAD GENETICS INC posted the faster year-over-year revenue change (-0.4% vs -4.0%). Over the past eight quarters, MYRIAD GENETICS INC's revenue compounded faster (1.9% CAGR vs -2.7%).

Monro, Inc. is an automotive services company founded and headquartered in Rochester, New York, U.S. As of 2025, Monro has 1,260 locations making them the second-largest automotive services company in North America after Driven Brands by number of locations and by revenue.

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

MNRO vs MYGN — Head-to-Head

Bigger by revenue
MNRO
MNRO
1.4× larger
MNRO
$293.4M
$209.8M
MYGN
Growing faster (revenue YoY)
MYGN
MYGN
+3.7% gap
MYGN
-0.4%
-4.0%
MNRO
Faster 2-yr revenue CAGR
MYGN
MYGN
Annualised
MYGN
1.9%
-2.7%
MNRO

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
MNRO
MNRO
MYGN
MYGN
Revenue
$293.4M
$209.8M
Net Profit
$11.1M
Gross Margin
34.9%
70.0%
Operating Margin
6.3%
-2.7%
Net Margin
3.8%
Revenue YoY
-4.0%
-0.4%
Net Profit YoY
143.1%
EPS (diluted)
$0.35
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MNRO
MNRO
MYGN
MYGN
Q4 25
$293.4M
$209.8M
Q3 25
$288.9M
$205.7M
Q2 25
$301.0M
$213.1M
Q1 25
$295.0M
$195.9M
Q4 24
$305.8M
$210.6M
Q3 24
$301.4M
$213.3M
Q2 24
$293.2M
$211.5M
Q1 24
$310.1M
$202.2M
Net Profit
MNRO
MNRO
MYGN
MYGN
Q4 25
$11.1M
Q3 25
$5.7M
$-27.4M
Q2 25
$-8.1M
$-330.5M
Q1 25
$-21.3M
$-100.0K
Q4 24
$4.6M
Q3 24
$5.6M
$-22.1M
Q2 24
$5.9M
$-36.7M
Q1 24
$3.7M
$-26.0M
Gross Margin
MNRO
MNRO
MYGN
MYGN
Q4 25
34.9%
70.0%
Q3 25
35.7%
69.9%
Q2 25
35.5%
71.2%
Q1 25
33.0%
68.5%
Q4 24
34.3%
71.7%
Q3 24
35.3%
70.2%
Q2 24
37.2%
69.6%
Q1 24
35.5%
68.1%
Operating Margin
MNRO
MNRO
MYGN
MYGN
Q4 25
6.3%
-2.7%
Q3 25
4.4%
-11.3%
Q2 25
-2.0%
-154.5%
Q1 25
-8.1%
-14.8%
Q4 24
3.3%
-18.6%
Q3 24
4.4%
-9.4%
Q2 24
4.5%
-17.3%
Q1 24
3.3%
-13.8%
Net Margin
MNRO
MNRO
MYGN
MYGN
Q4 25
3.8%
Q3 25
2.0%
-13.3%
Q2 25
-2.7%
-155.1%
Q1 25
-7.2%
-0.1%
Q4 24
1.5%
Q3 24
1.9%
-10.4%
Q2 24
2.0%
-17.4%
Q1 24
1.2%
-12.9%
EPS (diluted)
MNRO
MNRO
MYGN
MYGN
Q4 25
$0.35
$-0.09
Q3 25
$0.18
$-0.29
Q2 25
$-0.28
$-3.57
Q1 25
$-0.74
$0.00
Q4 24
$0.15
$-0.47
Q3 24
$0.18
$-0.24
Q2 24
$0.19
$-0.41
Q1 24
$0.12
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MNRO
MNRO
MYGN
MYGN
Cash + ST InvestmentsLiquidity on hand
$4.9M
$149.6M
Total DebtLower is stronger
$45.0M
$119.9M
Stockholders' EquityBook value
$604.9M
$368.0M
Total Assets
$1.6B
$706.6M
Debt / EquityLower = less leverage
0.07×
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MNRO
MNRO
MYGN
MYGN
Q4 25
$4.9M
$149.6M
Q3 25
$10.5M
$145.4M
Q2 25
$7.8M
$74.4M
Q1 25
$20.8M
$91.8M
Q4 24
$10.2M
$102.4M
Q3 24
$20.9M
$99.9M
Q2 24
$18.7M
$97.3M
Q1 24
$6.6M
$104.3M
Total Debt
MNRO
MNRO
MYGN
MYGN
Q4 25
$45.0M
$119.9M
Q3 25
$60.0M
$119.5M
Q2 25
$71.5M
Q1 25
$61.3M
Q4 24
$59.3M
Q3 24
$62.0M
Q2 24
$112.0M
Q1 24
$102.0M
Stockholders' Equity
MNRO
MNRO
MYGN
MYGN
Q4 25
$604.9M
$368.0M
Q3 25
$601.7M
$372.8M
Q2 25
$604.9M
$388.1M
Q1 25
$620.8M
$704.9M
Q4 24
$648.9M
$701.1M
Q3 24
$651.9M
$731.7M
Q2 24
$654.4M
$740.5M
Q1 24
$656.8M
$760.0M
Total Assets
MNRO
MNRO
MYGN
MYGN
Q4 25
$1.6B
$706.6M
Q3 25
$1.6B
$728.1M
Q2 25
$1.6B
$677.3M
Q1 25
$1.6B
$1.0B
Q4 24
$1.7B
$1.0B
Q3 24
$1.7B
$1.1B
Q2 24
$1.7B
$1.1B
Q1 24
$1.7B
$1.1B
Debt / Equity
MNRO
MNRO
MYGN
MYGN
Q4 25
0.07×
0.33×
Q3 25
0.10×
0.32×
Q2 25
0.12×
Q1 25
0.10×
Q4 24
0.09×
Q3 24
0.10×
Q2 24
0.17×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MNRO
MNRO
MYGN
MYGN
Operating Cash FlowLast quarter
$17.8M
$10.6M
Free Cash FlowOCF − Capex
$9.1M
FCF MarginFCF / Revenue
3.1%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
1.60×
TTM Free Cash FlowTrailing 4 quarters
$49.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MNRO
MNRO
MYGN
MYGN
Q4 25
$17.8M
$10.6M
Q3 25
$32.3M
$21.1M
Q2 25
$-1.9M
$-13.6M
Q1 25
$28.9M
$-16.3M
Q4 24
$14.8M
$6.6M
Q3 24
$62.6M
$700.0K
Q2 24
$25.6M
$2.6M
Q1 24
$-5.3M
$-18.6M
Free Cash Flow
MNRO
MNRO
MYGN
MYGN
Q4 25
$9.1M
Q3 25
$26.6M
Q2 25
$-9.3M
Q1 25
$23.2M
Q4 24
$7.9M
Q3 24
$57.6M
Q2 24
$16.8M
Q1 24
$-11.9M
FCF Margin
MNRO
MNRO
MYGN
MYGN
Q4 25
3.1%
Q3 25
9.2%
Q2 25
-3.1%
Q1 25
7.9%
Q4 24
2.6%
Q3 24
19.1%
Q2 24
5.7%
Q1 24
-3.8%
Capex Intensity
MNRO
MNRO
MYGN
MYGN
Q4 25
3.0%
Q3 25
2.0%
Q2 25
2.5%
Q1 25
1.9%
Q4 24
2.2%
Q3 24
1.6%
Q2 24
3.0%
Q1 24
2.1%
Cash Conversion
MNRO
MNRO
MYGN
MYGN
Q4 25
1.60×
Q3 25
5.71×
Q2 25
Q1 25
Q4 24
3.23×
Q3 24
11.08×
Q2 24
4.37×
Q1 24
-1.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MNRO
MNRO

Tires$150.2M51%
Maintenance$73.5M25%
Brakes$35.1M12%
Steering$24.9M8%
Batteries$6.2M2%
Exhaust$3.2M1%

MYGN
MYGN

Segment breakdown not available.

Related Comparisons